{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T22:51:49Z","timestamp":1789944709155,"version":"4.0.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["L'Enc\u00e9phale"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.encep.2008.04.008","type":"journal-article","created":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T04:40:03Z","timestamp":1222836003000},"page":"370-376","source":"Crossref","is-referenced-by-count":4,"title":["Les traitements psychotropes prescrits dans un \u00e9tablissement public de sant\u00e9 mentale accueillant des personnes atteintes d\u2019autisme et des polyhandicap\u00e9s"],"prefix":"10.1016","volume":"35","author":[{"given":"S.","family":"Armand-Branger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Poisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Gaudoneix-Ta\u00efeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.encep.2008.04.008_bib1","unstructured":"Agence nationale pour le d\u00e9veloppement de l\u2019\u00e9valuation m\u00e9dicale (ANDEM) - L\u2019autisme, Paris, 1994, 60 pages."},{"key":"10.1016\/j.encep.2008.04.008_bib2","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s002130050010","article-title":"5-HT3- and 5-HT2C- antagonist properties of cyamemazine: signifiance for its clinical anxiolytic activity","volume":"147","author":"Alvarez-Guerra","year":"2000","journal-title":"Psychopharmacology"},{"issue":"9","key":"10.1016\/j.encep.2008.04.008_bib3","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.4088\/JCP.v65n0907","article-title":"Treatement of behavior disorders in mental retardation: report on transitioning to atypical antipsychotics, with an emphasis on risperidone","volume":"65","author":"Aman","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.encep.2008.04.008_bib4","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1176\/ajp.142.8.939","article-title":"Problem with orders for medication as needed","volume":"142","author":"Ayd","year":"1985","journal-title":"Am J Psychiatry"},{"issue":"3","key":"10.1016\/j.encep.2008.04.008_bib5","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0013-7006(05)82394-2","article-title":"Descriptive study of psychotropic use in the 20\u201335 age adults with autism in Languedoc-Roussillon","volume":"31","author":"Baghdadli","year":"2005","journal-title":"Enc\u00e9phale"},{"issue":"1","key":"10.1016\/j.encep.2008.04.008_bib6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/026988110201600113","article-title":"A systematic review of use of atypical antipsychotics in autism","volume":"16","author":"Barnard","year":"2002","journal-title":"J Psychopharmacol"},{"issue":"3","key":"10.1016\/j.encep.2008.04.008_bib7","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1039-8562.2004.02099.x","article-title":"Audit of antipsychoic prescribing in a private psychiatric hospital","volume":"12","author":"Botvinik","year":"2004","journal-title":"Australas Psychiatry"},{"key":"10.1016\/j.encep.2008.04.008_bib8","first-page":"573","article-title":"Analyse des prescriptions de psychotropes dans un centre hospitalier psychiatrique","volume":"52","author":"Hida","year":"1997","journal-title":"Therapie"},{"issue":"1","key":"10.1016\/j.encep.2008.04.008_bib9","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0013-7006(04)95415-2","article-title":"Pharmaco-epidemiology of antipsychotic prescription practices for schizophrenic patients (1995\u20131998 cross sectional surveys)","volume":"30","author":"Lachaux","year":"2004","journal-title":"Enc\u00e9phale"},{"key":"10.1016\/j.encep.2008.04.008_bib10","unstructured":"Lachaux B. Enqu\u00eate sur les pratiques de prescription des neuroleptiques dans le secteur de psychiatrie publique. Halopsy no\u00a0 sp\u00e9cial, septembre 1997"},{"issue":"6","key":"10.1016\/j.encep.2008.04.008_bib11","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.pnpbp.2005.06.009","article-title":"Patterns of clinical use of antipsychotics in hospitalised psychiatric patients","volume":"29","author":"Mauri","year":"2005","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.encep.2008.04.008_bib12","first-page":"89","article-title":"La qualit\u00e9 de vie chez les patients psychotiques hospitalis\u00e9s","volume":"105","author":"Parquet","year":"1994","journal-title":"Synapse"},{"key":"10.1016\/j.encep.2008.04.008_bib13","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0924-9338(99)80713-5","article-title":"Polypharmacy in psychiatric treatment. Patterns of psychotropic drug use in Austrian psychiatric clinics","volume":"14","author":"Rittmannsberger","year":"1999","journal-title":"Eur Psychiatry"},{"issue":"1","key":"10.1016\/j.encep.2008.04.008_bib14","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1447-0349.2004.00304.x","article-title":"Psychotropic PRN\u00a0: a model for best practice management of acute psychotic behavioural disturbance in inpatient psychiatric settings","volume":"13","author":"Usher","year":"2004","journal-title":"Int J Ment Health Nurs"},{"key":"10.1016\/j.encep.2008.04.008_bib15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1055\/s-2007-979185","article-title":"Psychotropic drug prescription in a psychiatric University Hospital","volume":"32","author":"Voirol","year":"1999","journal-title":"Pharmacopsychiatry"}],"container-title":["L'Enc\u00e9phale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700608001656?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700608001656?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,25]],"date-time":"2018-12-25T05:53:17Z","timestamp":1545717197000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0013700608001656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S0013700608001656"],"URL":"https:\/\/doi.org\/10.1016\/j.encep.2008.04.008","relation":{},"ISSN":["0013-7006"],"issn-type":[{"value":"0013-7006","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}